CIK: 0001792206 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 12, 2025
Total Value ($000): $80,729 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CGON | CG Oncology, Inc. | 1,004,050 | $26,105 | 32.3% | $36.31 | -33.6% | COM | 156944100 |
| ALMS | Alumis Inc | 5,779,348 | $17,338 | 21.5% | $13.19 | -64.2% | COM | 022307102 |
| IRON | Disc Medicine, Inc. | 299,069 | $15,839 | 19.6% | $46.85 | +0.3% | COM | 254604101 |
| HIMS | Hims & Hers Health, Inc. | 273,151 | $13,617 | 16.9% | $8.41 | +437.7% | COM CL A | 433000106 |
| MAZE | Maze Therapeutics Inc | 345,191 | $4,235 | 5.2% | $12.04 | -13.6% | COM | 578784100 |
| LYEL | Lyell Immunopharma Inc | 406,652 | $3,595 | 4.5% | $9.11 | 0.0% | COM | 55083R203 |